Because this isn't CSI; it's real life. Tests are grueling and take time, and many end in failure. That we've come this far and are still conducting trials and new phases puts CUR at the forefront. If you have no patience, don't invest in stocks like this.
Sentiment: Strong Buy
This company is one of those cited by Motley Fool as the "future" of video streaming and other tech advances. Why is there little to no interest in it? I'm on the sidelines for now, but if I come into some cash, this would be one I would look closely at.
Having gone through a sale of my company more than once, that is exactly what new management brings to the table. They have to make the company as attractive as possible, and the way to do that is by cutting people and other major expenses. FUEL has a AI method that other companies want and don't want to go through the research trying to build their own. This company is — or will be — ripe for a sale.
I'm going to take a page from today's politicians and create my own truth about CUR: I think it is going to explode to the upside some day and I'm just stubborn enough to wait for that day. I've accumulated enough shares to make it a significant investment — or a costly mistake. Obviously, I'm betting on the stock to rebound in a big way at some point.
I bought more in the low $1.90s as well on Thursday. I've been in for four years now and have an average at just over $2.05 now.
Rocket Fuel has been plagued with multiple issues, primarily stemming from unsustainable growth.
Rocket Fuel has done an excellent job addressing concerns and taking advantage of opportunities.
After dropping 80% since its IPO, Rocket Fuel has a price to sales ratio of just over 1, which is ridiculous relative to its growth.
The acquisition of [x+1], growth in mobile, social and video channels and international expansion present tremendous opportunities for the company.
I've noticed considerable interest in the ALS community in Genervon's GM6. A friend who was diagnosed with ALS last year wonders why that drug hasn't been approved for use. Maybe this chatter has motivated CUR to get a bit more aggressive with PR. Just a thought.
With all these douche bags showing up on our message board, something good must be coming down the pike. I love the desperation.
Even as a long-term long, I'm impressed with this message from Jan. 12. Sure enough, we're almost at $2.80. Almost prescient!